Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Closed-Loop Glucagon Pump for PBH
NCT03255629Phase 2Completed
- Sponsor
- Joslin Diabetes Center
- Start
- Sep 2017
- Primary completion
- Aug 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glucagon in post-bariatric hypoglycemia (PBH) (2 arms), sponsored by Joslin Diabetes Center. Primary endpoints: Number of Participants With Meal-provoked Hypoglycemia, Defined as Sensor Glucose <65 mg/dL and Number of Participants With Meal-provoked Hypoglycemia, Defined as Plasma Glucose <65 mg/dL. Started Sep 2017; status: completed.
02
Drugs
glucagon
03
Conditions
post-bariatric hypoglycemia (PBH)
Beyond the preview
Go deeper on NCT03255629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03255629.